Croda International Plc (LON:CRDA - Get Free Report) insider Chris Good bought 1,000 shares of the company's stock in a transaction on Wednesday, August 6th. The stock was bought at an average cost of GBX 2,633 ($35.40) per share, for a total transaction of £26,330 ($35,399.30).
Croda International Price Performance
LON CRDA traded down GBX 92.34 ($1.24) during trading hours on Monday, reaching GBX 2,476.66 ($33.30). The company's stock had a trading volume of 12,632,609 shares, compared to its average volume of 1,155,030. The firm has a market capitalization of £3.46 billion, a price-to-earnings ratio of 21.28, a P/E/G ratio of 1.40 and a beta of 0.74. Croda International Plc has a 1-year low of GBX 2,470 ($33.21) and a 1-year high of GBX 4,335 ($58.28). The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. The company's 50-day moving average is GBX 2,920.43 and its two-hundred day moving average is GBX 2,998.67.
Croda International (LON:CRDA - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 ($0.97) EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. On average, equities analysts predict that Croda International Plc will post 181.8307268 EPS for the current year.
Analyst Ratings Changes
CRDA has been the subject of a number of analyst reports. JPMorgan Chase & Co. upgraded Croda International to an "overweight" rating in a research report on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft decreased their price target on Croda International from GBX 3,400 ($45.71) to GBX 3,000 ($40.33) and set a "hold" rating for the company in a research note on Tuesday, July 29th. Citigroup reduced their price objective on Croda International from GBX 3,550 ($47.73) to GBX 3,300 ($44.37) and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Finally, Berenberg Bank cut their price target on Croda International from GBX 3,800 ($51.09) to GBX 3,100 ($41.68) and set a "buy" rating on the stock in a report on Tuesday, July 29th.
Check Out Our Latest Analysis on Croda International
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Featured Articles

Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.